CT screening for lung cancer: Countdown to implementation

The Lancet Oncology

Volumn 14, Issue 13, 2013, Pages

  Field, John K ^a   Hansell, David M ^b   Duffy, Stephen W ^c   Baldwin, David R ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INCIDENTAL FINDING; INFORMATION DISSEMINATION; LUNG CANCER; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; RADIATION DOSE REDUCTION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SMOKING HABIT; THORAX RADIOGRAPHY; UNITED KINGDOM;

AGED; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; EUROPE; EVIDENCE-BASED MEDICINE; FEMALE; GREAT BRITAIN; HEALTH POLICY; HUMANS; INCIDENTAL FINDINGS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; SMOKING CESSATION; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES; UNNECESSARY PROCEDURES;

EID: 84888084277     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70293-6     Document Type: Review

References (77)

1. Patz EF, Goodman PC, Bepler G Screening for lung cancer. N Engl J Med 2000, 343:1627-1633.
2. Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011, 306:1865-1873.
3. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409. National Lung Screening Trial Research Team.
4. Providing guidance on lung cancer screening to patients and physicians American Lung Association, (accessed July 3, 2013). http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/lung-cancer-screening.pdf.
5. Jacobson FL, Austin JH, Field JK, et al. Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg 2012, 144:25-32.
6. Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012, 144:33-38.
7. NCCN clinical practice guidelines in oncology (NCCN Guidelines): lung cancer screening, V1.2014 National Comprehensive Cancer Network, (accessed July 3, 2013). http://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf.
8. Wender R, Fontham ET, Barrera E, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013, 63:106-117.
9. Pyenson BS, Sander MS, Jiang Y, Kahn H, Mulshine JL An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood) 2012, 31:770-779.
10. McMahon PM, Kong CY, Bouzan C, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011, 6:1841-1848.
11. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009, 361:2221-2229.
12. Xu DM, Gietema H, de Koning H, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006, 54:177-184.
13. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007, 120:868-874.
14. Pedersen J, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial: overall design and results of the prevalence round. J Thorac Oncol 2009, 5:608-614.
15. Infante M, Lutman FR, Cavuto S, et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 2008, 59:355-363. for the DANTE Study Group.
16. Becker N, Motsch E, Gross ML, et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 2012, 138:1475-1486.
17. Lopes Pegna A, Picozzi G, Mascalchi M, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009, 64:34-40.
18. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012, 21:308-315.
19. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 2011, 66:308-313.
20. Field JK, van Klaveren R, Pedersen JH, et al. European randomized lung cancer screening trials: post NLST. J Surg Oncol 2013, 108:280-286. on behalf of the European Randomized Screening Trial Group.
21. Pastorino U Early detection of lung cancer. Respiration 2006, 73:5-13.
22. Ashraf H, Tonnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Dossing M Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009, 64:388-392.
23. Calabro E, Randi G, La Vecchia C, et al. Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. Eur Respir J 2010, 35:146-151.
24. Sverzellati N, Cademartiri F, Bravi F, et al. Relationship and prognostic value of modified coronary artery calcium score, FEV1, and emphysema in lung cancer screening population: the MILD trial. Radiology 2012, 262:460-467.
25. Infante M, Chiesa G, Solomon D, et al. Surgical procedures in the DANTE trial, a randomized study of lung cancer early detection with spiral computed tomography: comparative analysis in the screening and control arm. J Thorac Oncol 2011, 6:327-335.
26. Roz L, Verri C, Conte D, et al. Plasma DNA levels in spiral CT-detected and clinically detected lung cancer patients: a validation analysis. Lung Cancer 2009, 66:270-271.
27. Sozzi G, Roz L, Conte D, et al. Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study. Am J Respir Crit Care Med 2009, 179:69-74.
28. Boeri M, Verri C, Conte D, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 2011, 108:3713-3718.
29. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease: the randomised Danish Lung Cancer Screening Trial-status after five annual screening rounds with low-dose CT. Thorax 2012, 67:296-301.
30. Infante M, Cavuto S, Lutman FR, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009, 180:445-453.
31. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012, 21:308-315.
32. Field JK, Smith RA, Duffy SW, et al. The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative group. J Thorac Oncol 2006, 1:497-498.
33. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003, 95:470-478.
34. Cassidy A, Myles JP, van Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008, 98:270-276.
35. Raji OY, Duffy SW, Agbaje OF, et al. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med 2012, 157:242-250.
36. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007, 99:715-726.
37. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 2011, 103:1058-1068.
38. Tammemagi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013, 368:728-736.
39. Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK Lung cancer risk prediction: a tool for early detection. Int J Cancer 2007, 120:1-6.
40. Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) 2012, 5:992-1006.
41. Field JK, Baldwin D, Devaraj A et al. United Kingdom lung cancer screening trial (UKLS): first 88897 approaches. American Association for Cancer Research annual meeting 2013; Washington, DC, USA; April 6-10, 2013. Abstract 1146.
42. Zwirewich CV, Mayo JR, Muller NL Low-dose high-resolution CT of lung parenchyma. Radiology 1991, 180:413-417.
43. Mettler FA, Huda W, Yoshizumi TT, Mahesh M Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008, 248:254-263.
44. Nair A, Screaton NJ, Holemans JA, et al. Performance of trained radiographers in lung nodule detection: prospective comparison with experienced radiologists in lung cancer screening. Insights Imaging 2013, 4(1 suppl):S385-S386. 10.1594/ecr2013/C-1377.
45. Pauli R, Hammond S, Cooke J, Ansell J Radiographers as film readers in screening mammography: an assessment of competence under test and screening conditions. Br J Radiol 1996, 69:10-14.
46. Duijm LE, Groenewoud JH, Fracheboud J, van Ineveld BM, Roumen RM, de Koning HJ Introduction of additional double reading of mammograms by radiographers: effects on a biennial screening programme outcome. Eur J Cancer 2008, 44:1223-1228.
47. Armato SG, Li F, Giger ML, MacMahon H, Sone S, Doi K Lung cancer: performance of automated lung nodule detection applied to cancers missed in a CT screening program. Radiology 2002, 225:685-692.
48. Awai K, Murao K, Ozawa A, et al. Pulmonary nodules at chest CT: effect of computer-aided diagnosis on radiologists' detection performance. Radiology 2004, 230:347-352.
49. Beyer F, Zierott L, Fallenberg EM, et al. Comparison of sensitivity and reading time for the use of computer-aided detection (CAD) of pulmonary nodules at MDCT as concurrent or second reader. Eur Radiol 2007, 17:2941-2947.
50. Roos JE, Paik D, Olsen D, et al. Computer-aided detection (CAD) of lung nodules in CT scans: radiologist performance and reading time with incremental CAD assistance. Eur Radiol 2010, 20:549-557.
51. van Ginneken B, Armato SG, de Hoop B, et al. Comparing and combining algorithms for computer-aided detection of pulmonary nodules in computed tomography scans: the ANODE09 study. Med Image Anal 2010, 14:707-722.
52. Godoy MC, Kim TJ, White CS, et al. Benefit of computer-aided detection analysis for the detection of subsolid and solid lung nodules on thin- and thick-section CT. AJR Am J Roentgenol 2013, 200:74-83.
53. Zhao Y, de Bock GH, Vliegenthart R, et al. Performance of computer-aided detection of pulmonary nodules in low-dose CT: comparison with double reading by nodule volume. Eur Radiol 2012, 22:2076-2084.
54. Henschke CI, Yip R, Yankelevitz DF, Smith JP Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2013, 158:246-252. the International Early Lung Cancer Action Program I.
55. Lam S, McWilliams A, Mayo J, Tammemagi M Computed tomography screening for lung cancer: what is a positive screen?. Ann Intern Med 2013, 158:289-290.
56. Launoy G, Duffy S, Prevost T, Bouvier V Detection of cancer, sensitivity of the test and sensitivity of the screening program. Rev Epidemiol Sante Publ 1998, 46:420-426. (in French).
57. Duffy SW, Hill C, Esteve J Quantitative methods for the evaluation of cancer screening 2001, Edward Arnold (OUP), London.
58. Chien CR, Chen TH Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int J Cancer 2008, 122:2594-2599.
59. Surveillance, epidemiology and end results (SEER) stat fact sheets: lung and bronchus National Cancer Institute, (accessed July 12, 2013). http://seer.cancer.gov/statfacts/html/lungb.html.
60. Ashraf H, Dirksen A, Loft A, et al. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning. Thorax 2011, 66:315-319.
61. van der Aalst CM, Van Den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax 2010, 65:600-605.
62. Chen YF, Madan J, Welton N, et al. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. Health Technol Assess 2012, 16:1-205.
63. Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Molken MP Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Thorax 2010, 65:711-718.
64. Jacobs PC, Mali WP, Grobbee DE, van der Graaf Y Prevalence of incidental findings in computed tomographic screening of the chest: a systematic review. J Comput Assist Tomogr 2008, 32:214-221.
65. Kucharczyk MJ, Menezes RJ, McGregor A, Paul NS, Roberts HC Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography. Can Assoc Radiol J 2011, 62:141-145.
66. van de Wiel JC, Wang Y, Xu DM, et al. Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT. Eur Radiol 2007, 17:1474-1482.
67. Aarup LR, Nahum AE, Zacharatou C, et al. The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: implications for tumour coverage. Radiother Oncol 2009, 91:405-414.
68. Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012, 61:1036-1040.
69. Weller D, Coleman D, Robertson R, et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007, 97:1601-1605.
70. Steele RJC Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004, 329:133.
71. NHS breast screening programme: annual review, 2012 2012, NHS, NHS Cancer Screening Programmes, Sheffield.
72. Vertinsky T, Forster B Prevalence of eye strain among radiologists: influence of viewing variables on symptoms. AJR Am J Roentgenol 2005, 184:681-686.
73. Tao C, Gierada DS, Zhu F, Pilgram TK, Wang JH, Bae KT Automated matching of pulmonary nodules: evaluation in serial screening chest CT. AJR Am J Roentgenol 2009, 192:624-628.
74. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012, 307:2418-2429.
75. Van Den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, van Klaveren RJ, de Koning HJ Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J 2011, 38:154-161.
76. Van Den Bergh KA, Essink-Bot ML, Borsboom GJ, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 2010, 102:27-34.
77. Field JK, Smith RA, Aberle DR, et al. International Association for the Study of Lung Cancer: computed tomography screening workshop, 2011 report. J Thorac Oncol 2012, 7:10-19.